Key result
Smartphone-based remote monitoring lowers systolic blood pressure by ~8 mmHg at 6 months.
Why the study?
Routine clinic-based monitoring for hypertension and type 2 diabetes can be difficult in Sub-Saharan Africa, and regional evidence on whether digital health tools can support long-term home-based management remained limited.
Does a smartphone-based remote home monitoring system improve blood pressure and fasting blood glucose control in adults with hypertension and/or type 2 diabetes in Accra, Ghana?
Cohort (n=481)
Yes
Does a smartphone-based remote home monitoring system improve blood pressure and fasting blood glucose control in adults with hypertension and/or type 2 diabetes in Accra, Ghana?
Smartphone-supported home monitoring in an urban Sub-Saharan African setting is feasible and associated with sustained reductions in blood pressure and blood pressure variability over 12 months, as well as fasting blood glucose improvements among patients uncontrolled at baseline.
May support smartphone remote monitoring for hypertension in Ghanaian outpatients; leaves open need for randomized trials before practice change.
Background Long-term conditions such as high blood pressure and type 2 diabetes are growing concerns in Sub-Saharan Africa, where routine clinic-based monitoring can be difficult. Digital health tools may help support home-based care, yet evidence from the region remains limited. This study examines whether a smartphone-based remote monitoring system can support long-term management of high blood pressure and fasting blood glucose among adults receiving care in Accra, Ghana. Methods We followed 481 adults aged 18-85 years with high blood pressure and/or type 2 diabetes who recorded home measurements through a smartphone remote-monitoring platform while attending three outpatient clinics. High blood pressure control was defined by age-specific thresholds, and fasting blood glucose control was defined as values below 7.0 millimoles per litre. We analysed changes in home measurements over time and identified factors associated with achieving control at twelve months. We also examined predictors of early blood pressure control using time-to-event analysis. Results Both systolic and diastolic blood pressure decrease significantly within six months and remain lower at twelve months and beyond. Individuals who begin with uncontrolled values show the largest improvements. Although overall fasting blood glucose does not change significantly, those uncontrolled at baseline show a meaningful decline over time. After one year, the proportion of individuals with controlled blood pressure increases from 39 percent to 62 percent, and most participants who start uncontrolled achieve at least one controlled reading during follow-up. Conclusions Smartphone-supported home monitoring is feasible in an urban African setting and is associated with meaningful long-term improvement in blood pressure. While reductions in fasting blood glucose are less consistent, the findings indicate that digital health tools can support chronic disease care and highlight opportunities to strengthen strategies for improving blood glucose control over time.
No takes yet. Share an insight, caveat, or question.
Andel et al. (2026) conducted a cohort in Hypertension and/or type 2 diabetes (n=481). Smartphone-based remote home monitoring platform (Luscii) vs. Baseline clinic measurements (pre-post comparison) was evaluated on Change in systolic blood pressure (SBP) at 6 months and controlled blood pressure at 12 months (MD -8.2 mmHg, p=<0.001). Smartphone-based remote monitoring reduced systolic blood pressure by 8.2 mmHg at 6 months (P<0.001) and increased controlled blood pressure from 39% to 62% at 1 year in Ghanaian adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: